XPH Holdings Information

XPH is an equity ETF with a total of 59 individual holdings. The top holdings are Organon & Co. stock at 3.89%, Corcept Therapeutics at 3.11%, Liquidia at 2.75%, Axsome Therapeutics at 2.66%, and Enliven Therapeutics at 2.50%.

Total Holdings

Top 10 Percentage

25.87%

Asset Class

Equity

ETF Category

Health

Assets

352.21M

PE Ratio

15.54

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	OGN	Organon & Co.	3.89%	1,023,723
2	CORT	Corcept Therapeutics Incorporated	3.11%	194,186
3	LQDA	Liquidia Corporation	2.75%	169,913
4	AXSM	Axsome Therapeutics, Inc.	2.66%	41,077
5	ELVN	Enliven Therapeutics, Inc.	2.50%	213,415
6	JAZZ	Jazz Pharmaceuticals plc	2.29%	35,333
7	TRVI	Trevi Therapeutics, Inc.	2.21%	548,729
8	VTRS	Viatris Inc.	2.19%	468,992
9	ESPR	Esperion Therapeutics, Inc.	2.16%	2,435,831
10	RPRX	Royalty Pharma plc	2.11%	140,326
11	DFTX	Definium Therapeutics, Inc.	2.10%	351,682
12	INDV	Indivior PLC	2.08%	199,568
13	MBX	MBX Biosciences, Inc.	2.05%	222,790
14	PRGO	Perrigo Company plc	2.01%	667,873
15	EWTX	Edgewise Therapeutics, Inc.	1.99%	211,417
16	HRMY	Harmony Biosciences Holdings, Inc.	1.94%	227,573
17	XERS	Xeris Biopharma Holdings, Inc.	1.92%	1,082,793
18	OMER	Omeros Corporation	1.91%	549,190
19	ANIP	ANI Pharmaceuticals, Inc.	1.90%	85,880
20	LLY	Eli Lilly and Company	1.87%	6,553
21	CRNX	Crinetics Pharmaceuticals, Inc.	1.85%	177,172
22	PCRX	Pacira BioSciences, Inc.	1.84%	286,983
23	INVA	Innoviva, Inc.	1.82%	292,231
24	OCUL	Ocular Therapeutix, Inc.	1.79%	689,666
25	LGND	Ligand Pharmaceuticals Incorporated	1.79%	29,614

Showing 25 of 59 holdings

Subscribe to see the full list

Activate Now

As of May 15, 2026